• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芬兰超级研究中精神障碍的一般医学共病情况。

General medical comorbidities in psychotic disorders in the Finnish SUPER study.

作者信息

Ahti Johan, Kieseppä Tuula, Haaki Willehard, Suvisaari Jaana, Niemelä Solja, Suokas Kimmo, Holm Minna, Wegelius Asko, Kampman Olli, Lähteenvuo Markku, Paunio Tiina, Tiihonen Jari, Hietala Jarmo, Isometsä Erkki

机构信息

Department of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Hospital District of Helsinki and Uusimaa, Helsinki, Finland.

出版信息

Schizophrenia (Heidelb). 2024 Dec 31;10(1):124. doi: 10.1038/s41537-024-00546-1.

DOI:10.1038/s41537-024-00546-1
PMID:39741144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11688420/
Abstract

Schizophrenia (SZ), schizoaffective disorder (SZA), bipolar disorder (BD), and psychotic depression (PD) are associated with premature death due to preventable general medical comorbidities (GMCs). The interaction between psychosis, risk factors, and GMCs is complex and should be elucidated. More research particularly among those with SZA or PD is warranted. We evaluated the association between registry-based psychotic disorders and GMC diagnoses in a large national sample of participants with different psychotic disorders. In addition, we examined whether body mass index (BMI) and smoking as risk factors for GMCs explain differences between diagnostic groups. This was a cross-sectional study of a clinical population of participants (n = 10,417) in the Finnish SUPER study. Registry-based diagnoses of psychotic disorders and hypertension, diabetes, chronic obstructive pulmonary disease (COPD), cancers, ischemic heart disease, and liver disorders were obtained. Participants' BMI and self-reported smoking were recorded. Total effect of diagnostic category adjusted for age and sex as well as direct effect including known risk factors was calculated using logistic regression. Regardless of diagnostic category, participants had high BMI (average 30.3 kg/m), and current smoking was common (42.4%). Diabetes and COPD were more common in SZ than in other diagnostic categories. The differences between psychotic disorders were not explained by obesity or smoking status only. Obesity and smoking were prevalent in all diagnostic categories of psychotic disorders, and continued efforts at prevention are warranted. Additional differences in GMC prevalence exist between psychotic disorders that are not explained by obesity and smoking.

摘要

精神分裂症(SZ)、分裂情感性障碍(SZA)、双相情感障碍(BD)和精神病性抑郁症(PD)与可预防的普通内科合并症(GMCs)导致的过早死亡相关。精神病、风险因素和GMCs之间的相互作用很复杂,需要阐明。尤其在患有SZA或PD的人群中进行更多研究很有必要。我们在一个包含不同精神病性障碍参与者的大型全国样本中,评估了基于登记的精神病性障碍与GMC诊断之间的关联。此外,我们研究了作为GMCs风险因素的体重指数(BMI)和吸烟是否能解释诊断组之间的差异。这是对芬兰SUPER研究中参与者(n = 10417)的临床人群进行的横断面研究。获得了基于登记的精神病性障碍以及高血压、糖尿病、慢性阻塞性肺疾病(COPD)、癌症、缺血性心脏病和肝脏疾病的诊断。记录了参与者的BMI和自我报告的吸烟情况。使用逻辑回归计算了调整年龄和性别后的诊断类别总效应以及包括已知风险因素的直接效应。无论诊断类别如何,参与者的BMI都很高(平均30.3 kg/m²),当前吸烟很常见(42.4%)。糖尿病和COPD在SZ中比在其他诊断类别中更常见。仅肥胖或吸烟状况并不能解释精神病性障碍之间的差异。肥胖和吸烟在所有精神病性障碍诊断类别中都很普遍,仍需继续努力进行预防。在未由肥胖和吸烟解释的精神病性障碍之间,GMC患病率还存在其他差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbbe/11688420/90cb6ff735b6/41537_2024_546_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbbe/11688420/86204436725c/41537_2024_546_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbbe/11688420/90cb6ff735b6/41537_2024_546_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbbe/11688420/86204436725c/41537_2024_546_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbbe/11688420/90cb6ff735b6/41537_2024_546_Fig2_HTML.jpg

相似文献

1
General medical comorbidities in psychotic disorders in the Finnish SUPER study.芬兰超级研究中精神障碍的一般医学共病情况。
Schizophrenia (Heidelb). 2024 Dec 31;10(1):124. doi: 10.1038/s41537-024-00546-1.
2
Differences in psychosocial functioning between psychotic disorders in the Finnish SUPER study.芬兰 SUPER 研究中精神病性障碍患者的心理社会功能差异。
Schizophr Res. 2022 Jun;244:10-17. doi: 10.1016/j.schres.2022.04.008. Epub 2022 May 7.
3
Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders.精神病患者一级亲属中心血管代谢功能障碍增加。
Schizophr Res. 2015 Jun;165(1):103-7. doi: 10.1016/j.schres.2015.03.034. Epub 2015 Apr 19.
4
Family Genetic Risk Scores and the Genetic Architecture of Major Affective and Psychotic Disorders in a Swedish National Sample.瑞典全国样本中的家族遗传风险评分与主要情感障碍和精神障碍的遗传结构
JAMA Psychiatry. 2021 Jul 1;78(7):735-743. doi: 10.1001/jamapsychiatry.2021.0336.
5
Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort.精神障碍和代谢综合征患者的免疫代谢特征。来自FACE-SZ队列的结果。
Brain Behav Immun Health. 2022 Mar 29;22:100436. doi: 10.1016/j.bbih.2022.100436. eCollection 2022 Jul.
6
Factors associated with overweight and obesity in schizophrenia, schizoaffective and bipolar disorders.与精神分裂症、分裂情感性障碍和双相情感障碍患者超重和肥胖相关的因素。
Psychiatry Res. 2016 Mar 30;237:304-10. doi: 10.1016/j.psychres.2016.01.024. Epub 2016 Jan 14.
7
Anxiety disorder comorbidity in bipolar disorder, schizophrenia and schizoaffective disorder.双相障碍、精神分裂症和分裂情感性障碍中的焦虑障碍共病。
Psychopathology. 2013;46(3):176-85. doi: 10.1159/000339556. Epub 2012 Aug 16.
8
Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder.精神分裂症相关多基因易感性与双相情感障碍中情绪不一致性精神病性症状的发生及程度之间的关联
JAMA Psychiatry. 2018 Jan 1;75(1):28-35. doi: 10.1001/jamapsychiatry.2017.3485.
9
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study.使用多个多基因风险评分区分首发样本中的精神分裂症谱系障碍和情感性精神病类别;EU-GEI 研究。
Psychol Med. 2023 Jun;53(8):3396-3405. doi: 10.1017/S0033291721005456. Epub 2022 Jan 25.
10
The association between serum creatine kinase, mood and psychosis in inpatients with schizophrenia, bipolar and schizoaffective disorders.血清肌酸激酶与精神分裂症、双相情感障碍和分裂情感性障碍住院患者的情绪和精神病之间的关联。
Psychiatry Res. 2016 Apr 30;238:333-337. doi: 10.1016/j.psychres.2016.01.058. Epub 2016 Feb 3.

本文引用的文献

1
Integrating Electronic Health Records and Polygenic Risk to Identify Genetically Unrelated Comorbidities of Schizophrenia That May Be Modifiable.整合电子健康记录和多基因风险以识别精神分裂症可能可改变的非遗传共病。
Biol Psychiatry Glob Open Sci. 2024 Feb 28;4(3):100297. doi: 10.1016/j.bpsgos.2024.100297. eCollection 2024 May.
2
Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders.遗传因素对精神障碍患者疾病严重程度和病程进展的影响:超级芬兰队列研究,该队列纳入了 10403 名患者。
Mol Psychiatry. 2024 Sep;29(9):2733-2741. doi: 10.1038/s41380-024-02516-6. Epub 2024 Apr 1.
3
Antipsychotic-Induced Metabolic Syndrome: A Review.
抗精神病药引起的代谢综合征:综述。
Metab Syndr Relat Disord. 2023 Aug;21(6):294-305. doi: 10.1089/met.2023.0003. Epub 2023 Jun 22.
4
Cohort profile: SUPER-Finland - the Finnish study for hereditary mechanisms of psychotic disorders.队列简介:SUPER-Finland - 芬兰精神障碍遗传机制研究。
BMJ Open. 2023 Apr 12;13(4):e070710. doi: 10.1136/bmjopen-2022-070710.
5
Lancet Diabetes & Endocrinology Commission on the Definition and Diagnosis of Clinical Obesity.《柳叶刀-糖尿病与内分泌学》临床肥胖症定义与诊断委员会
Lancet Diabetes Endocrinol. 2023 Apr;11(4):226-228. doi: 10.1016/S2213-8587(23)00058-X. Epub 2023 Mar 3.
6
Early start of anti-dementia medication is associated with lower health and social care costs in Alzheimer´s patients: a Finnish nationwide register study.抗痴呆药物的早期使用与阿尔茨海默病患者较低的健康和社会护理成本相关:一项芬兰全国性登记研究
Eur J Health Econ. 2023 Dec;24(9):1421-1428. doi: 10.1007/s10198-022-01553-8. Epub 2022 Nov 30.
7
Mortality in psychotic depression: 18-year follow-up study.精神病性抑郁症的死亡率:18 年随访研究。
Br J Psychiatry. 2023 Jan;222(1):37-43. doi: 10.1192/bjp.2022.140.
8
Obesity and metabolic state are associated with increased healthcare resource and medication use and costs: a Finnish population-based study.肥胖和代谢状态与增加的医疗资源和药物使用及成本有关:一项芬兰基于人群的研究。
Eur J Health Econ. 2023 Jul;24(5):769-781. doi: 10.1007/s10198-022-01507-0. Epub 2022 Sep 5.
9
Contribution of smoking change to 45-year trend in prevalence of chronic bronchitis in Finland.吸烟变化对芬兰慢性支气管炎流行率 45 年趋势的贡献。
Scand J Public Health. 2023 Dec;51(8):1189-1195. doi: 10.1177/14034948221104351. Epub 2022 Jun 19.
10
Differences in psychosocial functioning between psychotic disorders in the Finnish SUPER study.芬兰 SUPER 研究中精神病性障碍患者的心理社会功能差异。
Schizophr Res. 2022 Jun;244:10-17. doi: 10.1016/j.schres.2022.04.008. Epub 2022 May 7.